The portability of the BD FACSPresto system and its ability to accurately measure three critical parameters (AbsCD4, CD4%, and Hb levels) that reflect the clinical status of people living with HIV/AIDS makes it well-suited for use as a point-of-care CD4 testing technology. Here, GSTM1 is linked to AIDS.